[Side effects of therapy and management].
Ciocca
Mirta
M
Hospital de Pediatría "Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires.
Daruich
Jorge
J
Fernández
Nora
N
D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a